<prompt> Pfupisa nyaya yacho: Mushonga unoshandura zvinhu, unonzi ibrutinib, uyo unobvisa kenza ungakurumidza kupiwa varwere vane mamwe marudzi echirwere chacho. Mufananidzo womufananidzo. Mushonga unoshandura zvinhu uyo unobvisa kenza ungakurumidza kupiwa varwere vane mamwe marudzi echirwere chacho. Kana vakapiwa mushonga, piritsi rinotorwa kamwe chete pazuva, rinonzi ibrutinib, rinogona kuita kuti varwere vane kenza yeropa vasatambure nemigumisiro inoshungurudza inokonzerwa nokurapwa nemakemikari. Ibrutinib ndeimwe yemishonga mitsva mishoma ichaitwa kuti iwanikwe kuburikidza neCancer Drugs Fund mushure mekuedzwa kaviri muzvirwere zve 28 zveBritish zvakaratidza kuti inoshanda zvakanyanya pakurapa mantle cell lymphoma MCL uye chronic lymphocytic leukemia CLL. Purofesa Stephen Devereux, chiremba wezvechirwere cheropa paKings College Hospital muLondon, anoti irudzi rutsva rwemishonga inonangwa, inozivikanwa seBrutons tyrosine kinase inhibitor. Inoshanda nokurwisa uye kudzima puroteni iri mumasero ekenza. Chemotherapy inouraya masero ekenza asi inourayawo masero akanaka uye naizvozvo ine migumisiro yakawanda,anodaro. Sezvo mushonga uyu wakanangidzirwa pamasero eB, migumisiro yacho mishoma. Mukuwedzera, varwere havafaniri kupinda muchipatara kuti vaitwe. Anenge munhu mumwe muvanhu 25 achaonekwa aine kenza yeropa muupenyu hwake - kana kuti vanhu 25 000 gore roga roga muUK. Pakati paivava, 2.800 vachava neCLL, rudzi rwakajairika zvikurusa rweleukemia, uye 500 vachava neMCL, rudzi rusingawanzoitiki rweB-cell lymphoma. Pari zvino, mushonga weibrutinib unodhura kusvika pa 74 000 pagore uchapiwa chete kuvarwere vane chirwere chisingapinduri pakurapwa nemakemikari, kana kuti vaya vakadzokororazve kurapwa nemakemikari. Asi kuedza kushandisa mushonga wacho somushonga wokutanga kuri kuitikawo. Purofesa Devereux anoti: Tiri kutarisira ramangwana risina mishonga yemakemikari, kunyange zvazvo tisati tasvika ipapo. Mushonga uyu unoita kuti chirwere chive chisina ngozi. Haisi mushonga zvirwere izvi hazvirapiki asi zvinozvichinja kuva zvirwere zvisingaperi. Tinotoziva kuti inogona kushanda nokuda kwe...  <response>: Ibrutinib ichaitwa kuti iwanikwe kuburikidza neCancer Drugs Fund mushure mekuedzwa kaviri. Miedzo, muzvipatara zveBritain 28, yakaratidza kuti inoshanda zvikuru mukurapa mantle cell lymphoma uye chronic lymphocytic leukemia. Pari zvino, ibrutinib inodhura kusvika pa 74,000 pagore ichapiwa chete kuvarwere vane chirwere chisingapinduri kurapwa nemakemikari. 